Literature DB >> 22507622

Effects of NKG2D haplotypes on the cell-surface expression of NKG2D protein on natural killer and CD8 T cells of peripheral blood among atomic-bomb survivors.

Kazue Imai1, Tomonori Hayashi, Mika Yamaoka, Junko Kajimura, Kengo Yoshida, Yoichiro Kusunoki, Kei Nakachi.   

Abstract

NKG2D is a primary activating receptor that triggers cell-mediated cytotoxicity in NK cells against tumor and virus-infected cells. We previously identified the NKG2D haplotypes in the natural killer gene complex region on chromosome 12p. Two major haplotype alleles, LNK1 and HNK1, were closely related to low and high natural cytotoxic activity phenotypes, respectively. Furthermore, the haplotype of HNK1/HNK1 has revealed a decreased risk of cancer compared with LNK1/LNK1. In the present study, using flow cytometry, we evaluated the functional effects of NKG2D haplotypes and five htSNPs in terms of the cell-surface expression of NKG2D protein on NK and CD8 T cells of peripheral blood among 732 atomic-bomb survivors. NKG2D expression on NK cells showed significant increases, in the order of LNK1/LNK1, LNK1/HNK1 and HNK1/HNK1 haplotypes (p for trend=0.003), or with major homozygous, heterozygous, and minor homozygous genotypes for individual htSNPs (p for trend=0.02-0.003). The same trend was observed for NKG2D expression on CD8 T cells. Our findings indicate that the NKG2D haplotypes are associated with the expression levels of NKG2D protein on NK and CD8 T cells, resulting in inter-individual variations in human cytotoxic response.
Copyright © 2012 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22507622     DOI: 10.1016/j.humimm.2012.03.003

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  3 in total

Review 1.  Recent Advances in Molecular Mechanisms of the NKG2D Pathway in Hepatocellular Carcinoma.

Authors:  Jian Wang; Cun-Di Li; Lin Sun
Journal:  Biomolecules       Date:  2020-02-14

2.  A functional variant in the immune signalling receptor NKG2D alters skin cancer risk.

Authors:  Karin A Vineretsky; Evidio Domingo-Musibay; Margaret R Karagas; DeAnn Lazovich; Jacquelyn K Kuriger-Laber; DeVon Hunter-Schlichting; Heather H Nelson
Journal:  Br J Dermatol       Date:  2022-03-23       Impact factor: 9.302

3.  Influence of NKG2D Genetic Variants on Response to Anti-TNF Agents in Patients with Rheumatoid Arthritis.

Authors:  Milena Iwaszko; Jerzy Świerkot; Katarzyna Kolossa; Sławomir Jeka; Piotr Wiland; Katarzyna Bogunia-Kubik
Journal:  Genes (Basel)       Date:  2018-01-25       Impact factor: 4.096

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.